TWD
AVIR icon

True Wealth Design’s Atea Pharmaceuticals AVIR Stock Holding History

True Wealth Design’s Portfolio AVIR Stock Details AVIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$568 Buy
+122
New +$607 ﹤0.01% 2167

Other funds holding AVIR

CWP
Curated Wealth Partners El Segundo, California $774M AUM 5.71% 1-Year Est. Return
CAC
Certified Advisory Corp Altamonte Springs, Florida $1.24B AUM 21.71% 1-Year Est. Return
RA
RFG Advisory Birmingham, Alabama $6.4B AUM 19.93% 1-Year Est. Return
FIA
FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.12B AUM 34.21% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

True Wealth Design's AVIR Position: Q2 2026 in Review

True Wealth Design opened a new position in Atea Pharmaceuticals (AVIR) in Q2 2026: 122 shares worth $568. The stake represents ﹤0.01% of the portfolio and ranks #2167 among its holdings.

8 funds tracked by Wall St. Rank hold AVIR as of Q2 2026.

  • True Wealth Design held 122 shares of Atea Pharmaceuticals worth $568 as of Q2 2026.
  • Atea Pharmaceuticals was a new True Wealth Design position in Q2 2026.
  • Atea Pharmaceuticals made up ﹤0.01% of True Wealth Design's portfolio in Q2 2026, its #2167 holding.
  • 8 funds tracked by Wall St. Rank held Atea Pharmaceuticals as of Q2 2026.

Based on True Wealth Design's 13F filing for Q2 2026, filed 16 Jul 2026.